SciClone Pharmaceuticals News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

04.05.18	Accuray Incorporated Reports Inducement Awards Under NASDAQ Listing Rules (PR Newswire)
30.10.17	ChipEstimate.com Launches New Compare IP Tool (PR Newswire)
13.10.17	Consortium Led By GL Capital Completes Acquisition Of SciClone (PR Newswire)
12.10.17	NMI Holdings and Axcelis Technologies Set to Join S&P SmallCap 600 (PR Newswire)
17.08.17	SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of SciClone Pharmaceuticals, Inc. - SCLN (PR Newswire)
16.08.17	Breakfast Technical Briefing on Drug Makers Stocks -- Depomed, Synergy Pharma, Novo Nordisk, and SciClone Pharma (PR Newswire)
10.08.17	SciClone Announces End Of Go-Shop Period With No Parties Designated As Excluded Parties (PR Newswire)
09.08.17	SciClone Reports Second Quarter 2017 Financial Results (PR Newswire)
03.07.17	Lifshitz&Miller LLP Announces Investigation of ARI Network Services, Inc., DuPont Fabros Technology, Inc., Nexvet Biopharma Public Limited Company, PAREXEL International Corporation, Rice Energy Inc. (PR Newswire)
28.06.17	Daily Technical Summary Reports on Drug Makers Stocks -- Apricus Biosciences, DURECT, Sucampo Pharma, and SciClone Pharma (PR Newswire)
19.06.17	SCICLONE INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of SciClone Pharmaceuticals, Inc. (PR Newswire)
09.06.17	Gainers & Losers Of June 8: ANAB, INO, SCLN, NLNK, JUNO... (RTTNews)
08.06.17	SciClone Pharmaceuticals Moves Notably Higher On Buyout (RTTNews)
08.06.17	SciClone Announces Merger; Consortium To Acquire SciClone For $11.18/shr (RTTNews)
08.06.17	SciClone Enters Into Definitive Merger Agreement To Be Acquired By Consortium Led By GL Capital (PR Newswire)
11.05.17	FDA Nod For MRK's Keytruda, SGMO Soars On Gene Therapy Deal, OMER Catches Eyes (RTTNews)
04.05.17	SciClone Pharmaceuticals To Report First Quarter 2017 Financial Results On May 10, 2017 (PR Newswire)
27.03.17	SciClone To Present At Needham Healthcare Conference On April 4, 2017 (PR Newswire)
20.03.17	How These Drug Makers Stocks are Faring? -- Orexigen Therapeutics, United Therapeutics, DURECT, and SciClone Pharma (PR Newswire)
21.02.17	SciClone Pharmaceuticals To Report Fourth Quarter And Full Year 2016 Financial Results On March 6, 2017 (PR Newswire)
09.02.17	Healthcare Stocks Under Scanner -- Aerie Pharma, GW Pharma, Retrophin, and SciClone Pharma (PR Newswire)
01.02.17	SciClone To Present At BIO CEO & Investor Conference On February 13, 2017 (PR Newswire)
15.11.16	FDA Snubs DVAX, Keep An Eye On OCUL, It's All Green For BLUE (RTTNews)
20.07.16	SCLN Withdraws From Auction Block, ZFGN Tumbles, Double Blessing For VRX (RTTNews)
05.02.16	SCLN Settles FCPA Charges, OGXI On Cost Discipline Mode, Shire To Face FDA (RTTNews)
27.05.15	SciClone Granted Development And Commercial Rights For Telavancin In China (RTTNews)
06.01.15	SciClone Pharma Backs 2014 Outlook (RTTNews)
06.01.15	Sciclone Pharma Backs Year-end 2014 Outlook - Quick Facts (RTTNews)
28.08.14	SciClone Pharma, BTG Say China's FDA Approves DC Bead (RTTNews)
28.08.14	BTG And SciClone Say DC Bead Gets Approved By China FDA - Quick Facts (RTTNews)
12.03.14	SciClone Pharmaceuticals Q4 Profit Down (RTTNews)
09.01.14	SciClone Expects FY14 Sales Revenue Of $130 Mln- $135 Mln (RTTNews)
15.07.13	SciClone Names Wilson Cheung CFO, Senior VP Finance - Quick Facts (RTTNews)
31.01.05	SciClone to Report Fourth Quarter 2004 Results on February 23, 2005 (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Sonova Hldg	302.80	1.30 %	K V
Alcon	76.88	0.65 %	K V
Sika	218.00	0.37 %	K V
Kuehne+Nagel Int	202.60	-0.20 %	K V
Logitech Intl	78.28	-0.33 %	K V
ABB	49.25	-1.44 %	K V
Holcim	87.68	-1.55 %	K V
Zurich Insur Gr	531.20	-1.63 %	K V
Roche Hldg G	267.20	-1.69 %	K V
UBS Group	29.78	-1.94 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu SciClone Pharmaceuticals Inc.

Aktien Top/Flop

Meistgelesene Nachrichten